Non-coding gene linked to core social and behavioural traits in Autism, major SickKids-led study finds
Summary:
Nature study implicates PTCHD1-AS in Autism’s core features, opening a new window into its biological roots.
Key study findings
- Identifies how changes to a long non-coding gene called PTCHD1-AS is linked to an increased likelihood of ASD in males
- Changes were associated with social interactions and repetitive behaviours, without affecting cognitive abilities such as learning and memory
- PTCHD1-AS alters synaptic plasticity in a brain circuit connecting the cortex to the striatum
Findings help separate the biology of core ASD traits from cognitive impairment and show that this non-coding gene plays a distinct role in ASD biology.
A long‑overlooked stretch of the human genome appears to play a distinct role in shaping the social and stereotypic repetitive behaviours that define Autism Spectrum Disorder (ASD), without affecting learning or other cognitive abilities, according to a major new study published in Nature.
A research team led by The Hospital for Sick Children (SickKids) has pinpointed PTCHD1-AS, a long non-coding RNA gene on the X chromosome, as a contributor to increased likelihood of ASD in males. Notably, deletions within PTCHD1-AS influence social interaction and repetitive behaviours, while leaving cognition unaffected.
While there are around 100 genes and copy number variations linked to ASD, most encode proteins and are linked to a wide range of developmental outcomes. These findings help distinguish the biological mechanisms underlying Autism’s hallmark behavioural traits from those involved in other brain functions.
“PTCHD1-AS gives us a new entry point to study the biology of ASD, sharpening our understanding of how specific biological pathways relate to key autism traits. This is essential, because no new therapeutics in clinical trials are designed to modulate the main features of ASD,” says senior author Dr. Stephen Scherer, Senior Scientist, Genetics & Genome Biology and Chief of Research at SickKids, and Director of the McLaughlin Centre at the University of Toronto.
A non-coding gene with a distinct role
Roughly one in 50 children and youth in Canada have ASD. Despite the diverse ways they experience the condition, changes in social interaction and repetitive behaviours are common across the spectrum.
Long non‑coding RNAs (lncRNAs), such as PTCHD1-AS, regulate how other genes become turned on and off and until recently have been largely unexplored. Researchers targeted PTCHD1-AS because it sits in a region close to other protein-coding genes that together have been linked to ASD and intellectual disability.
In studying genomic data from over 9,300 individuals in global databases, they discovered that dozens of deletions of the X-linked PTCHD1‑AS were associated with increased ASD susceptibility in males (females have a backup X chromosome).
Follow‑up studies using mouse models developed by the research team further reinforced these findings. Male mice lacking PTCHD1-AS showed changes only in social behaviour and increased repetitive actions while they behaved typically in learning, memory and attention tasks.
“Our findings suggest there is a different biology involved with our PTCHD1-AS model compared to other ASD protein-coding models,” says Dr. Lisa Bradley, first author and Research Associate in The Centre for Applied Genomics (TCAG) at SickKids.
How PTCHD1-AS influences brain circuitry
What was happening in the brains of these mice? The team found that disrupting PTCHD1‑AS affected “synaptic plasticity,” the brain’s ability to adapt and fine-tune signals in response to activity, inside the striatum, where repetitive behaviours are regulated.
“When we examined gene and protein expression in this area, we saw changes in genes and proteins involved in regulating synaptic plasticity as well as myelination, the process that allows electrical signals to travel faster between neurons. This gives us a molecular pattern we can use for future studies into the biological effect of this non-coding gene in the brain,” adds Bradley.
They traced these changes to reduced activity of protein kinase C in a specific brain circuit connecting the cortex to the striatum, alongside increases in two forms of synaptic plasticity.
“Through a multi-disciplinary approach combining human genetics, mouse models, multi-omics and electrophysiology, we’ve connected a non-coding gene to measurable changes in brain function,” says study co-author Dr. Graham Collingridge, Senior Investigator at Lunenfeld-Tanenbaum Research Institute, Sinai Health and Director of the Tanz Centre for Research in Neurodegenerative Diseases and Professor in the Department of Physiology at Temerty Faculty of Medicine at the University of Toronto.
“Together, our research helps clarify how unique alterations in synaptic plasticity relate to the core features of autism.”
Toward a more precise understanding of ASD biology
The research team notes by linking a specific gene and biological pathway to social and repetitive behaviours, these findings may be relevant across all ASD diagnoses, regardless of clinical complexity.
Next steps for the research include deeper investigation of the molecular, cellular and circuit-level pathways influenced by PTCHD1-AS to identify potential targets driving those core features of ASD and thereby inform future precision therapeutics for those who seek them.
Scherer, who is also a Professor in the Department of Molecular Genetics at Temerty Faculty of Medicine at University of Toronto, adds: “Beyond significantly advancing our understanding of Autism as a human condition, the study shows how small changes in DNA can influence complex human behaviour.”
“It’s amazing to me how much of our disposition is genetically ‘hardwired,’ even in the traits that shape how we connect and interact,” he says.
The study was funded through support from Autism Speaks, Autism Science Foundation, Canada Foundation for Innovation (CFI), Canadian Institutes of Health Research (CIHR), Genome Canada and Ontario Genomics, the Government of Ontario, Ontario Brain Institute, the Province of Ontario Neurodevelopment Disorders (POND) Network, Simons Foundation Autism Research Initiative, University of Toronto McLaughlin Centre and SickKids Foundation.